Literature DB >> 27932390

Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children.

David M Lewinsohn1, Michael K Leonard2, Philip A LoBue3, David L Cohn4, Charles L Daley5, Ed Desmond6, Joseph Keane7, Deborah A Lewinsohn1, Ann M Loeffler8, Gerald H Mazurek3, Richard J O'Brien9, Madhukar Pai10, Luca Richeldi11, Max Salfinger12, Thomas M Shinnick3, Timothy R Sterling13, David M Warshauer14, Gail L Woods15.   

Abstract

BACKGROUND: Individuals infected with Mycobacterium tuberculosis (Mtb) may develop symptoms and signs of disease (tuberculosis disease) or may have no clinical evidence of disease (latent tuberculosis infection [LTBI]). Tuberculosis disease is a leading cause of infectious disease morbidity and mortality worldwide, yet many questions related to its diagnosis remain.
METHODS: A task force supported by the American Thoracic Society, Centers for Disease Control and Prevention, and Infectious Diseases Society of America searched, selected, and synthesized relevant evidence. The evidence was then used as the basis for recommendations about the diagnosis of tuberculosis disease and LTBI in adults and children. The recommendations were formulated, written, and graded using the Grading, Recommendations, Assessment, Development and Evaluation (GRADE) approach.
RESULTS: Twenty-three evidence-based recommendations about diagnostic testing for latent tuberculosis infection, pulmonary tuberculosis, and extrapulmonary tuberculosis are provided. Six of the recommendations are strong, whereas the remaining 17 are conditional.
CONCLUSIONS: These guidelines are not intended to impose a standard of care. They provide the basis for rational decisions in the diagnosis of tuberculosis in the context of the existing evidence. No guidelines can take into account all of the often compelling unique individual clinical circumstances.
© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2016        PMID: 27932390     DOI: 10.1093/cid/ciw694

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  105 in total

1.  Multidrug-Resistant Tuberculosis in Patients with Human Immunodeficiency Virus. Management Considerations within High-resourced Settings.

Authors:  John W Wilson; Diana M Nilsen; Suzanne M Marks
Journal:  Ann Am Thorac Soc       Date:  2020-01

2.  Tuberculosis: where are we?

Authors:  Fernanda Carvalho de Queiroz Mello; Denise Rossato Silva; Margareth Pretti Dalcolmo
Journal:  J Bras Pneumol       Date:  2018-04       Impact factor: 2.624

3.  A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology.

Authors:  J Michael Miller; Matthew J Binnicker; Sheldon Campbell; Karen C Carroll; Kimberle C Chapin; Peter H Gilligan; Mark D Gonzalez; Robert C Jerris; Sue C Kehl; Robin Patel; Bobbi S Pritt; Sandra S Richter; Barbara Robinson-Dunn; Joseph D Schwartzman; James W Snyder; Sam Telford; Elitza S Theel; Richard B Thomson; Melvin P Weinstein; Joseph D Yao
Journal:  Clin Infect Dis       Date:  2018-08-31       Impact factor: 9.079

Review 4.  Tuberculosis in Children.

Authors:  Tania A Thomas
Journal:  Pediatr Clin North Am       Date:  2017-08       Impact factor: 3.278

5.  The role of medical history in the diagnostic process of unexplainable weight loss.

Authors:  Antonio Mirijello; Maria Maddalena D'Errico; Stefano Notarangelo; Salvatore De Cosmo
Journal:  BMJ Case Rep       Date:  2019-07-10

6.  A Comparative Analysis of Pulmonary and Critical Care Medicine Guideline Development Methodologies.

Authors:  Noah C Schoenberg; Alan F Barker; John Bernardo; Robin R Deterding; Jerrold J Ellner; Dean R Hess; Neil R MacIntyre; Fernando J Martinez; Kevin C Wilson
Journal:  Am J Respir Crit Care Med       Date:  2017-09-01       Impact factor: 21.405

Review 7.  Xpert Ultra versus Xpert MTB/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis.

Authors:  Jerry S Zifodya; Jonah S Kreniske; Ian Schiller; Mikashmi Kohli; Nandini Dendukuri; Samuel G Schumacher; Eleanor A Ochodo; Frederick Haraka; Alice A Zwerling; Madhukar Pai; Karen R Steingart; David J Horne
Journal:  Cochrane Database Syst Rev       Date:  2021-02-22

8.  Coinfection of Tuberculosis in an Undiagnosed HIV, AIDS Patient Presenting With Shortness of Breath, Constitutional Symptoms and Lymphadenopathy.

Authors:  Mirian V Garcia Rivera; Angel Aponte; War War Ko
Journal:  Cureus       Date:  2021-06-25

Review 9.  Xpert® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance.

Authors:  Mikashmi Kohli; Ian Schiller; Nandini Dendukuri; Keertan Dheda; Claudia M Denkinger; Samuel G Schumacher; Karen R Steingart
Journal:  Cochrane Database Syst Rev       Date:  2018-08-27

10.  Development of a random forest model to classify sarcoidosis and tuberculosis.

Authors:  Jun Ma; Hongyun Yin; Xiaohui Hao; Wei Sha; Haiyan Cui
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.